What the Eye Exam Documentation Generator actually produces

PATIENT NAME: Maya Thornton | DOB: [verify from record] | AGE: 42 | SEX: Female | DATE OF EXAM: [current date] | EXAMINER: [Optometrist Name], O.D. [License#] CHIEF COMPLAINT: "Blurry vision at distance and eye strain after screen use." HISTORY OF PRESENT ILLNESS: Patient reports gradual onset of distance blur, more noticeable at work and while driving. Denies pain, flashing lights, or floaters. Experiences mild eye strain after prolonged computer use; no significant visual obstruction or diplopia. Symptoms present for approximately 3–6 months [verify]. Last comprehensive exam 3 years ago with significant refractive change expected. OCULAR HISTORY: Denies prior ocular surgery, injury, or disease. No prior glasses or contact lens wear reported [verify]. [No ocular contraindications noted — verify]. SYSTEMIC HISTORY: Hypertension (HTN), managed with lisinopril [dose not provided — verify]. Denies diabetes, thyroid disease, autoimmune conditions, or other systemic diseases [verify all]. Allergies: [not provided — verify]. Current medications: lisinopril [dosage — verify]. FAMILY HISTORY: [Not provided — verify]. SURGICAL HISTORY: [Not provided — verify]. EXAMINATION FINDINGS: VISUAL ACUITY: - Uncorrected (sc): OD 20/80, OS 20/60 - Best corrected with old Rx: OD 20/40, OS 20/30 - Pinhole: [not provided — verify] PUPILS: Pupils equal, round, reactive to light (PERRL); no afferent pupillary defect (APD) observed. COVER TEST: Orthophoria at distance and near (6 meters and 40 cm). EXTERNAL EXAMINATION: - Lids and lashes: Clear, no edema, lagophthalmos, or ptosis - Lacrimal apparatus: [not provided — verify] - Conjunctiva: Quiet, non-injected, no lesions OU - Corneas: Clear OU, no epithelial defects, scars, or dystrophy - Anterior chambers: Deep and quiet bilaterally, no cells or flare SLIT LAMP EXAMINATION: - Iris: Normal architecture, no rubeosis, normal pigmentation OU - Lens: Clear OU, no cataracts, vacuoles, or opacities - Angle: [Not examined — verify; recommend gonioscopy if narrow angle suspected] INTRAOCULAR PRESSURE (IOP): - OD: 16 mmHg (Goldmann applanation tonometry) - OS: 15 mmHg (Goldmann applanation tonometry) - Both within normal limits [reference range verify]. REFRACTION: - Manifest refraction: OD −2.25 −0.50 × 180, OS −1.75 −0.25 × 170 - Best corrected visual acuity achieved: OD 20/20, OS 20/20 [verify] - No astigmatism over 0.50 D OU DILATED FUNDUS EXAMINATION (pupils dilated with [agent — verify, approx. time of dilation]): - Optic disc: Well-defined margins OU. Cup-to-disc ratio (C/D): 0.3 OU. Normal neuroretinal rim color and contour. No pallor, hemorrhages, or swelling. - Macula: Flat, foveolar reflex intact OU. No exudates, edema, or drusen. [Macular thickness — verify if OCT not performed] - Retinal vessels: Normal caliber, color, and crossing patterns OU. No hemorrhages, microaneurysms, or cotton-wool spots. - Peripheral retina: Intact OU; no holes, detachments, or lattice degeneration. Vitreous: Clear OU, no opacities or hemorrhage. - Posterior pole: No drusen or signs of age-related macular degeneration. ADDITIONAL TESTING: - Confrontation visual fields: Full OU [confirm; formal perimetry not performed] - Color vision: [Not documented — verify with Ishihara or similar] ASSESSMENT & DIAGNOSIS: 1. Myopia, bilateral, progressive: OD −2.25 −0.50 × 180 / OS −1.75 −0.25 × 170. Significant refractive change from prior exam 3 years ago suggests myopic progression; recommend monitoring for continued change. 2. Digital eye strain / Asthenopia: Consistent with refractive error and prolonged near work (computer use). Symptoms expected to improve with updated correction and behavioral modifications. 3. IOP and fundoscopy: Within normal limits OU. No signs of glaucoma, retinal disease, or optic nerve pathology at this time. PLAN: REFRACTION: - Updated spectacle prescription issued: OD −2.25 −0.50 × 180 / OS −1.75 −0.25 × 170. Patient counseled on expected change in acuity and comfort. - Consider blue-light filtering lens coating or lenses to reduce strain from screen exposure [patient opted in/deferred — verify]. Discussed but not ordered today [verify patient preference]. - Contact lens fitting: Not discussed [verify if patient interested]. COUNSELING: - Discussed 20-20-20 rule for screen use: Every 20 minutes of near work, look 20 feet away for 20 seconds to reduce accommodation fatigue. - Advised on proper monitor distance (arm's length, ~28–30 inches) and screen height (top of screen at or below eye level). - Suggested adequate room lighting and reduced glare to minimize strain. - Discussed role of refractive error in digital eye strain; updated glasses should improve symptoms significantly. FOLLOW-UP: - Routine follow-up in 12 months to monitor myopic progression and recheck IOP, optic disc, and retinal status. - Earlier follow-up if symptoms worsen, floaters develop, flashing lights appear, or vision changes acutely. Patient instructed to contact if any vision-threatening symptoms occur [route to emergency care instructions — verify]. - Monitor for signs of glaucoma, myopic maculopathy, or other age-related conditions. Patient at [low/moderate/high] risk based on family history [not provided — verify] and prior eye health. DILATION: - Tropicamide 1% and phenylephrine 2.5% instilled bilaterally for dilated examination. Dilation expected to last approximately 4–6 hours. Patient counseled: sensitivity to light is normal; advise sunglasses if outdoors. Driving safety: advised to wait at least 2 hours before operating motor vehicle or defer driving until next day [per protocol — verify]. Patient confirmed understanding. MEDICATION ALLERGY/REACTIONS: [Not provided — verify]. SIGNATURE: [Examiner Name, O.D.] | LICENSE #: [Verify] | DATE: [Date of exam]

PRIMARY DIAGNOSES: 1. Myopia, bilateral, progressive — OD −2.25 −0.50 × 180 / OS −1.75 −0.25 × 170 [ICD-10: H52.1 — verify specific bilateral code and laterality] - Significant refractive shift from 3-year prior exam; myopic progression is expected finding in adult-onset or progressing myopia. - Corrects to 20/20 OU with new spectacle prescription. - No associated complications (myopic degeneration, posterior staphyloma) detected at this time; peripheral retina intact. 2. Asthenopia (digital eye strain) — secondary to refractive error and prolonged near accommodation [ICD-10: H53.14 — verify code] - Symptoms expected to resolve with updated spectacle correction + behavioral modifications (20-20-20 rule, monitor ergonomics). - No corneal abrasion, dry eye disease, or accommodation dysfunction documented at this time [dry eye — verify with osmolarity, tear breakup time if symptoms persist after refraction update]. CONFIRMATORY FINDINGS: - Best corrected acuity: 20/20 OU with new prescription confirms refractive etiology. - IOP (16 OD, 15 OS) and optic disc (C/D 0.3 OU) normal; no secondary glaucoma or ocular hypertension. - Dilated fundus: retinae intact OU, no hemorrhages, exudates, drusen, or retinal detachment. - Anterior segment healthy; no corneal or lens pathology. CLINICAL REASONING: Patient presents with progressive myopia, a common finding in this age group (early 40s; age-related accommodation loss also likely contributing to perceived strain). The 3-year gap since last exam and refractive shift of approximately 0.5 D OU suggests continued myopic progression. Updated correction resolves uncorrected VA deficit and should significantly improve comfort during near tasks. Digital eye strain is expected consequence of higher myopic error and increased screen time (occupational). No ocular pathology identified to explain symptoms; prognosis for symptom resolution is good with correction and ergonomic adjustments. Routine monitoring appropriate; no urgent intervention required.

FOLLOW-UP TIMELINE: - Routine comprehensive exam in 12 months (May 2027) to reassess refractive status, monitor for further myopic progression, and confirm stable optic disc and IOP. - If myopic progression continues at current rate, more frequent monitoring (every 6–12 months) may be warranted to assess for myopic maculopathy or other progressive changes [per guideline — verify]. MONITORING PARAMETERS: 1. Refractive Status: Document sphere, cylinder, and axis at each visit. Trend myopic shift over time to identify accelerating progression or plateauing (common in early adulthood). 2. Visual Acuity: Both uncorrected and best corrected; compare to baseline and year-on-year trends. 3. Intraocular Pressure: Measure at each visit via applanation tonometry (consistent method and time of day); establish baseline and monitor for elevated pressures (especially given family history unknown — verify). Alert threshold: >21 mmHg or rises >2–3 mmHg year-on-year. 4. Optic Disc and Retinal Status: Perform dilated fundus exam annually; assess C/D ratio, neuroretinal rim thickness, retinal status (especially macula in myopes > −6.00 D) for myopic degeneration, macular holes, retinal detachment risk. 5. Symptoms: Ask at each visit: persistent eye strain despite correction, new floaters, flashing lights, field defects, blurred vision, pain. REFERRAL TRIGGERS & ESCALATION CRITERIA: - IOP ≥ 21 mmHg sustained on repeat measurement, or acute rise ≥3 mmHg: refer to glaucoma specialist for formal perimetry, OCT optic nerve head, and gonioscopy [per protocol — verify]. - Optic disc changes: progressive C/D enlargement, notching, rim thinning, or hemorrhage: refer to ophthalmology for glaucoma vs. optic nerve pathology evaluation. - New or progressive symptoms (floaters, photopsia, scotoma, pain, vision loss): urgent referral to ophthalmology to rule out retinal break, detachment, or acute pathology. Patient instructed: If sudden vision loss, flashing lights, many new floaters, or eye pain occurs, seek immediate emergency care [verify ER routing instructions in your system]. - Fundal changes: Any new drusen, macular changes, retinal hemorrhage, or peripheral lesions: refer to ophthalmology or retinal specialist as clinically indicated. - Contact lens-related concerns: If patient desires contact correction despite glasses, perform baseline keratometry and fluorescein fitting; refer to specialty CL practitioner if Dk/L, fit, or material questions arise. PATIENT EDUCATION REINFORCEMENT: - Reiterate 20-20-20 rule and screen ergonomics at each visit; ask patient if they have implemented changes and assess symptom improvement. - Counsel on myopic progression: explain that continued close work and possible genetic factors may drive further refractive shift; regular monitoring is key. - Discuss myopic maculopathy risk if progression accelerates (especially if approaching −6.00 D or higher): early detection and specialist referral important for visual health. - Encourage annual eye exams (minimum) given refractive history and need to monitor for glaucoma risk (especially if family history reveals glaucoma — verify with patient). - Advise on UV protection (wear sunglasses) and healthy behaviors (balanced diet with antioxidants) to support long-term eye health [guideline — verify]. LENS & CORRECTION OPTIONS FOR FUTURE DISCUSSION: - Blue-light filtering lenses: If strain persists, offer blue-light coating for future glasses as add-on. - Contact lenses: Myopia management options (e.g., orthokeratology, soft contact lenses, or specialized designs) can slow myopic progression [per guideline — verify]; discuss if patient interested and meets candidacy [verify criteria]. - Multifocal or progressive lenses: As near-focusing demands increase and accommodation declines (typical in 40s–50s), multifocals may improve overall visual comfort [defer until next exam unless patient reports near-vision strain].